Page last updated: 2024-11-02

oxybutynin and Endometrial Neoplasms

oxybutynin has been researched along with Endometrial Neoplasms in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.

Research Excerpts

ExcerptRelevanceReference
"To assess how women in Sweden with breast cancer (BC), endometrial cancer (EC), and/or pulmonary embolism (PE) were dispensed menopausal hormone therapy (HT)."1.51Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study. ( Fredrikson, M; Hammar, M; Hoffmann, M; Lindh-Åstrand, L; Spetz Holm, AC, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindh-Åstrand, L1
Hoffmann, M1
Fredrikson, M1
Hammar, M1
Spetz Holm, AC1

Other Studies

1 other study available for oxybutynin and Endometrial Neoplasms

ArticleYear
Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study.
    Maturitas, 2019, Volume: 123

    Topics: Aged; Breast Neoplasms; Cohort Studies; Contraindications, Drug; Endometrial Neoplasms; Estrogen Rep

2019